Expression and putative biological roles of lipoxygenases and leukotriene receptors in leukemia and lymphoma.

Autor: Claesson HE; Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden. Electronic address: hans-erik.claesson@ki.se., Sjöberg J; Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden; NDA Group, Stockholm, Sweden. Electronic address: jan.sjoberg@ndareg.com., Xu D; Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden. Electronic address: dawei.xu@ki.se., Björkholm M; Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden. Electronic address: magnus.bjorkholm@regionstockholm.se.

Publikováno v: Prostaglandins & other lipid mediators [Prostaglandins Other Lipid Mediat] 2024 Oct; Vol. 174, pp. 106871. Date of Electronic Publication: 2024 Jul 09.

Kristinsson SY, Pfeiffer RM, Björkholm M, et al. Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood. 2010;115(24):.

Publikováno v: In Blood 7 April 2011 117(14):3938-3938

Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas.

Autor: Arffman M; Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Meriranta L; Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Autio M; Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Holte H; Department of Oncology, Oslo University Hospital and KG Jebsen Centre for B Cell Malignancies, Oslo, Norway., Jørgensen J; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Brown P; Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Jyrkkiö S; Department of Oncology, Turku University Hospital, Turku, Finland., Jerkeman M; Department of Oncology, Skane University Hospital, Lund, Sweden., Drott K; Department of Oncology, Skane University Hospital, Lund, Sweden., Fluge Ø; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Björkholm M; Department of Medicine, Karolinska University Hospital, Stockholm, Sweden., Karjalainen-Lindsberg ML; Department of Pathology, Helsinki University Hospital, Helsinki, Finland., Beiske K; Department of Pathology, Oslo University Hospital, Oslo, Norway., Pedersen MØ; Department of Pathology, Zealand University Hospital, Roskilde, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Leivonen SK; Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Leppä S; Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland. Electronic address: sirpa.leppa@helsinki.fi.

Publikováno v: Med (New York, N.Y.) [Med] 2024 Jun 14; Vol. 5 (6), pp. 583-602.e5. Date of Electronic Publication: 2024 Apr 04.

Splenectomised Hodgkin lymphoma patients: does severe pneumococcal disease pose a problem today and what is the best long-term strategy?

Autor: Weibull CE; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Sjöberg J; Department of Medicine, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.; NDA Group, Stockholm, Sweden., Dickman PW; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Björkholm M; Department of Medicine, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1942-1944. Date of Electronic Publication: 2023 Sep 14.

Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre-ibrutinib era: A population-based study.

Autor: Steingrímsson V; Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Lund SH; Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Dickman PW; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden., Weibull CE; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Solna, Sweden., Björkholm M; Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden., Landgren O; Myeloma Program, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA., Kristinsson SY; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.

Publikováno v: European journal of haematology [Eur J Haematol] 2022 Feb; Vol. 108 (2), pp. 145-153. Date of Electronic Publication: 2021 Nov 11.